Testing effectiveness (Phase 2)Study completedNCT02451514
What this trial is testing
Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)
Who this might be right for
Meningococcal DiseaseInfections, Meningococcal
GlaxoSmithKline 129